Human Side- PEP, Immunoglobulin & Behavioural Gaps
A bite is just the beginning. India’s real struggle with rabies lies in the critical hours that follow—where poor wound care, low vaccine completion, and a massive shortage of immunoglobulin turn a manageable exposure into a tragic, preventable death.
Rabies deaths are ultimately decided not on the street where a dog bites, but in the hours and weeks afterwards – in how people clean wounds, whether they reach a facility in time, what that facility stocks, and whether they complete every dose. That human chain in India still has multiple weak links.
7.1 Ideal vs. real post‑bite pathway
The ideal WHO‑aligned pathway after a suspected rabid animal bite is straightforward:
- Immediate wound care – vigorous washing with soap and running water for at least 15 minutes, plus povidone‑iodine or similar antiseptic.
- Rapid risk assessment – categorise exposure as Category I/II/III; decide on vaccine ± RIG.
- Post‑exposure prophylaxis (PEP) – initiate an approved intradermal (ID) or intramuscular (IM) schedule, typically 3–5 doses over 1–4 weeks.
- Rabies immunoglobulin (RIG) – infiltrate thoroughly into and around all Category III wounds (deep, multiple, head/neck/hand bites).
- Completion and follow‑up – ensure all doses are taken on schedule; monitor for adverse events.
By contrast, multiple Indian studies and NRCP field reports show a much more fragmented reality:
- Many victims do not wash wounds properly; a recent clinic‑based study found that while ~90% reported washing, only ≈11% did so for the recommended 15 minutes with soap and running water.
- A hospital study from Nagpur (2024–25) reported that 86% of bite victims had a delay in initiation of PEP, often beyond 24 hours.
- A classic Himachal Pradesh study found ~69% of patients reached a health facility only after 24 hours, often after visiting traditional healers and home‑remedy attempts.
These gaps mean that the virus often gets a crucial head start before biomedical interventions begin.
7.2 PEP completion: the 57–60% ceiling
Even when PEP is started, many Indian patients fail to complete the full course, leaving them at risk.
- A 2025 systematic review and meta‑analysis of Indian PEP compliance across multiple regions found an overall completion rate of just 57%, with most drop‑off occurring after the second or third dose.
- Earlier individual studies reported completion rates in the 54–78% range for the traditional 28‑day intradermal schedule, with better adherence for severe bites than for “minor” Category II exposures.
- The meta‑analysis also found higher compliance with intradermal regimens than intramuscular, likely because ID is cheaper and often delivered at specialised anti‑rabies clinics rather than general outpatient departments.
The new ICMR community survey mirrors this picture at population level: about 80% of bite victims receive at least one vaccine dose, but roughly half of them do not complete all scheduled doses, implying ~40–50% completion nationally. In rabies, stopping halfway is almost as dangerous as never starting.
Key reasons for non‑completion, recurring across studies, include:
- Economic barriers – transport costs, lost wages, and, in some states, out‑of‑pocket costs for later doses.
- Time/availability issues – long queues, clinic timings clashing with work, repeat travel to distant facilities.
- Perception of low risk – early doses reduce anxiety; once the wound “looks fine,” families assume further doses are unnecessary.
- Poor counselling – inadequate explanation from providers on why every dose matters.
Recent WHO‑backed guidance and Indian studies suggest that shorter ID regimens – e.g., the “1‑week, 3‑dose” schedule – may improve completion, and some states like Himachal Pradesh have piloted this in response to vaccine shortages. But regimen optimisation will only go so far without behaviour‑change work and system support.
7.3 Delays: when every hour counts
Timeliness is as important as completion. A 2025 cross‑sectional study from Nagpur’s anti‑rabies clinic provides a granular look at why people arrive late:
- 86% of 184 bite patients experienced a delay in starting PEP.
- Dogs accounted for 90% of bites, primarily on hands and legs.
- The most frequently cited reasons for delay were:
- Referral from one health centre to another (22.8%).
- Facility closed or services unavailable (17.9%).
- Non‑availability of vaccine at the first facility (16.3%).
- Travel distance and cost, family obligations and low perceived severity for “small” wounds.
Earlier qualitative work in hill districts paints the same picture: long distances to clinics, foot travel, and initial reliance on home remedies or traditional healers create a multi‑day lag. One patient quoted in a Himachal study had to walk 5 km and travel 15 km by road to reach a centre, arriving on the third day after the bite.
In a disease where the virus can traverse nerves at 12–24 mm per day and where bites on the face or head can have incubation times of just days to weeks, these delays are not minor – they are often fatal.
7.4 The RIG bottleneck: a 20% availability problem
If PEP completion is one Achilles’ heel, rabies immunoglobulin (RIG) availability is the other. RIG is essential for Category III exposures – deep, multiple, or head/neck/hand bites – because it provides immediate neutralising antibodies at the wound before vaccine‑induced immunity kicks in.
A nationwide health‑facility survey published in June 2025 quantified this gap:
- Anti‑rabies vaccine (ARV) was available in ≈80% of public‑sector facilities, though with regional variation.
- RIG was available in only about 20% of facilities overall.
- Availability varied hugely by facility type: as low as 1.8% in urban primary health centres and up to ≈70% in medical colleges.
In practice, this means that a villager bitten severely on the face or hand may reach a PHC where vaccine is available but RIG is not; they may be referred upwards, losing precious hours or days, or simply never receive RIG at all.
A 2025 analysis of RIG availability and policy options summarised the challenge:
- RIG is expensive, cold‑chain dependent and often centrally procured in limited quantities, leading to stock‑outs in lower‑tier facilities.
- Distribution is urban‑biased, with tertiary centres far better stocked than rural and peri‑urban facilities.
- Without RIG, clinicians often must rely on vaccine alone even in high‑risk exposures, hoping that early vaccine and wound care suffice.
Monoclonal antibody products – recombinant substitutes for human or equine RIG – offer a promising way out, with potential for cheaper, more scalable and more thermostable options. India’s biologics industry is well‑placed to lead production, but as of early 2026, uptake into NRCP protocols and large‑scale procurement is still emerging, not mainstream.
7.5 Behavioural and cultural barriers: myths, healers and fear
System constraints intersect with deeply rooted beliefs and practices. Studies from multiple states document a range of traditional responses to dog bites:
- Application of red chilli, turmeric, oils, lime, ash or herbal pastes to wounds instead of washing with soap and water.
- Seeking care from traditional healers, faith healers or local “bone‑setters” before, or instead of, visiting medical facilities.
- Underestimation of apparent “small bites” or scratches, especially in children, based on the belief that only deep wounds are dangerous.
A 2022 KAP (Knowledge, Attitudes, Practices) study in a rural community explicitly concluded that “management of dog‑bite wounds encompasses various myths, false beliefs, and inappropriate practices”, emphasising the need for sustained awareness campaigns. Meanwhile, a 2025 national analysis of local wound care noted that although >90% of respondents reported “washing,” only around one in ten followed WHO‑recommended washing duration and technique.
Fear and stigma play a role too. Families may delay seeking care for young girls due to concerns about travel and modesty; some patients may worry about injection side‑effects more than rabies itself. Without targeted communication, these psychosocial factors silently erode PEP effectiveness.
7.6 Economic cost of PEP – and why prevention at the dog level is cheaper
A 2025 economic analysis of rabies PEP and associated costs highlighted the financial burden on both households and health systems:
- Direct medical costs (vaccines, RIG, clinic visits) and indirect costs (transport, lost wages) can be substantial for low‑income families, especially when multiple visits and long distances are involved.
- At national scale, India spends hundreds of crores annually on PEP, yet still loses thousands of people to rabies – a stark illustration that PEP alone, without upstream dog‑side control, is an expensive but incomplete strategy.
These economics strengthen the core public‑health argument for CNVR and dog vaccination: every rabid dog prevented upstream saves multiple PEP courses and lives downstream.
7.7 Closing the human‑side gaps: what works
Evidence from Goa, Kerala, Sikkim and other pilots suggests several high‑yield interventions on the human side:
- Intensive, local IEC – repeated campaigns emphasising three messages:
- Wash any bite or scratch immediately with soap and water for 15 minutes.
- Seek medical care the same day, even for seemingly minor wounds.
- Complete every vaccine dose; “feeling fine” is not a reason to stop.
- School‑based education – programmes in Goa and Sikkim show meaningful gains (≈20–40%) in children’s knowledge of rabies and correct post‑bite actions, with real‑world cases of children insisting on PEP after being bitten.
- Service redesign – extended clinic hours, dedicated anti‑rabies clinics, SMS reminders and ASHA follow‑up for subsequent doses improve adherence, as documented in several PEP‑delivery analyses.
- Decentralised RIG availability – placing RIG (or monoclonal alternatives) at all district hospitals and selected CHCs would remove one of the most dangerous bottlenecks, though this requires procurement reforms and budgetary prioritisation.
–Abhinav Gerela
